Indonesian Drug Makers Squeezed By Raw Material, Fuel Costs

The Indonesian Pharmaceutical Association said the country's drug making industry has begun to suffer the high price of raw materials imported from China. The prices of some branded drugs in Indonesia already have doubled as a result of having to pass on the higher production costs due to as much as 95 percent increases in some materials. The head of the association said that in general the Indonesia prices of branded drugs have increase by between 5 percent and 10 percent," below the increase manufacturers would make if their consumers were not already facing their financial squeeze due to the cost of fuel. (Click here for more